Ivet Etchegaray-Morales
Overview
Explore the profile of Ivet Etchegaray-Morales including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
137
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Mendoza-Pinto C, Etchegaray-Morales I, Munguia-Realpozo P, Rojas-Villarraga A, Osorio-Pena A, Mendez-Martinez S, et al.
J Clin Rheumatol
. 2023 Oct;
30(1):1-7.
PMID: 37798834
Objective: To describe the results from the Global Burden Disease (GBD) study 2019 on the burden of other musculoskeletal (MSK) disorders in Latin America and the Caribbean (LAC). Methods: In...
12.
Mendoza-Pinto C, Etchegaray-Morales I, Munguia-Realpozo P, Solis-Poblano J, Osorio-Pena A, Zarate-Arellano D, et al.
Clin Rheumatol
. 2023 Sep;
43(1):1-13.
PMID: 37775642
Objective: This study aimed to describe the disease burden and trends of musculoskeletal (MSK) disorders in Mexico from 1990 to 2019. Method: A cross-sectional study using systematic analysis from the...
13.
Mendoza-Pinto C, Etchegaray-Morales I, Munguia-Realpozo P, Osorio-Pena A, Mendez-Martinez S, Ramirez-Lara E, et al.
Lupus
. 2023 Sep;
32(11):1328-1334.
PMID: 37705367
Background: Low disease activity state (LDAS) has been linked to a significant reduction in flares and damage accrual in patients with systemic lupus erythematosus (SLE); however, the effect of LDAS...
14.
Mendoza-Pinto C, Etchegaray-Morales I, Munguia-Realpozo P, Mendez-Martinez S, Ayon-Aguilar J, Arellano-Avendano F, et al.
Calcif Tissue Int
. 2023 Jul;
113(5):475-480.
PMID: 37481761
The Systemic Lupus International Clinics (SLICC)-Frailty Index (FI) is associated with adverse outcomes in systemic lupus erythematosus (SLE). However, to our knowledge, its association with bone mineral density (BMD) and...
15.
Munguia-Realpozo P, Mendoza-Pinto C, Etchegaray-Morales I, Solis-Poblano J, Ayon-Aguilar J, Ramirez-Lara E, et al.
Rheumatol Int
. 2023 Jun;
43(9):1611-1619.
PMID: 37349634
The study aimed to analyze the influence of the COVID-19 pandemic on mortality rates in patients with systemic autoimmune rheumatic diseases (SARD) in Mexico. We selected SARD-related deaths using National...
16.
Munguia-Realpozo P, Mendoza-Pinto C, Etchegaray-Morales I, Osorio-Pena A, Velez-Pelcastre S, Escamilla-Marquez M, et al.
Horm Metab Res
. 2023 May;
55(7):487-492.
PMID: 37178683
The aims of this study were in systemic lupus erythematosus (SLE) patients: 1) to compare the metabolomic profile of insulin resistance (IR) with controls and 2) to correlate the metabolomic...
17.
Mendoza-Pinto C, Etchegaray-Morales I, Ugarte-Gil M
Rheumatology (Oxford)
. 2023 Mar;
62(Suppl 1):i30-i35.
PMID: 36987603
SLE increases disease burden in those affected with it, and that is particularly the case in low- and middle-income countries. The 2019 Addressing Lupus Pillar of Health Advancement project is...
18.
Munguia-Realpozo P, Etchegaray-Morales I, Mendoza-Pinto C, Mendez-Martinez S, Osorio-Pena A, Ayon-Aguilar J, et al.
Autoimmun Rev
. 2023 Feb;
22(5):103294.
PMID: 36791873
Objective: We carried out a systematic review (SR) of adherence in diagnostic and prognostic applications of ML in SLE using the Transparent Reporting of a multivariable prediction model for Individual...
19.
Mendoza-Pinto C, Etchegaray-Morales I, Munguia-Realpozo P, Solis-Poblano J, Mendez-Martinez S, Osorio-Pena A, et al.
Lupus
. 2022 Sep;
31(13):1679-1684.
PMID: 36128770
Background: Hospitalizations due to systemic lupus erythematosus (SLE) incur substantial resource use. Hospitalization trends provide a key benchmark of the disease burden. However, there is little long-term data in Mexico....
20.
Munguia-Realpozo P, Mendoza-Pinto C, Garcia-Carrasco M, Escarcega R, Berra-Romani R, Etchegaray-Morales I, et al.
Lupus
. 2022 Sep;
31(13):1639-1648.
PMID: 36123774
Background: Patients with systemic lupus erythematosus (SLE) have an increased cardiovascular (CV) risk. Insulin resistance (IR), which is higher in patients with SLE, adversely impacts left ventricular (LV) remodeling and...